MSCs Stem Cells with Severe COVID-19 ARDS

There is an ongoing critical need to improve therapeutic strategies for COVID-19 pneumonia, particularly in the most severely affected patients. Adult mesenchymal stem cell (MSC) infusions have the potential to benefit critically ill patients with acute respiratory syndrome SARS-COV-2 infection, but clinical data supporting efficacy are lacking.

Read More »

Stem Cells and Covid-19 Recovery

Most infected people will develop mild to moderate illness and recover without hospitalization having common symptoms such as dry cough, tiredness and light fever. Patients affected with a severe illness due to Sars-Cov-2 usually have difficulty breathing, chest pain or pressure, loss of speech or movement. Latest Stem Cells treatments showed promising results when medication […]

Read More »